Mavacamten in Obstructive Hypertrophic Cardiomyopathy Patients Referred for Septal Reduction: Health Status Analysis Through Week 56 in VALOR-HCM Trial. - Desai, Milind Y.; Owens, Anjali; Wolski, Kathy; Geske, Jeffrey B.; Saberi, Sara; Wang, Andrew; Sherrid, Mark; Cremer, Paul C.; Lakdawala, Neal K.; Tower-Rader, Albree; Fermin, David; Naidu, Srihari S.; et al. (Journal of the American College of Cardiology (JACC), 2024)